These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6433786)

  • 1. Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1984 Jul; 26(1):1-4. PubMed ID: 6433786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Pennington JE
    Antimicrob Agents Chemother; 1984 Jan; 25(1):49-52. PubMed ID: 6538397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
    Kemmerich B; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1986 Mar; 29(3):395-9. PubMed ID: 2940970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
    Comber KR; Basker MJ; Osborne CD; Sutherland R
    Antimicrob Agents Chemother; 1977 Jun; 11(6):956-64. PubMed ID: 406837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shinners E
    J Infect Dis; 1985 Feb; 151(2):291-4. PubMed ID: 3155780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin.
    Prociv P
    Med J Aust; 1979 Jul; 2(2):63-4. PubMed ID: 114740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF; Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin.
    Robertson IF
    Med J Aust; 1979 Sep; 2(6):312-3. PubMed ID: 118324
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: comparison of aerosol and systemic administration.
    Makhoul IR; Merzbach D; Lichtig C; Berant M
    J Infect Dis; 1993 Nov; 168(5):1296-9. PubMed ID: 8228367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
    Gordin FM; Hackbarth CJ; Scott KG; Sande MA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):452-4. PubMed ID: 3159336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibiotic regimens for treatment of experimental pneumonia due to Pseudomonas.
    Pennington JE; Stone RM
    J Infect Dis; 1979 Dec; 140(6):881-9. PubMed ID: 120384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
    Pennington JE; Johnson CE; Platt R
    J Infect Dis; 1982 Oct; 146(4):567. PubMed ID: 6214595
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE
    Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
    Parry MF; Neu HC
    Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.